Global Summit on

Toxicology and Risk Assessment

Paris, France   October 25-26, 2018

Call for Abstract

  • Track 1-1: In Vitro Toxicity Testing
  • Track 1-2: Pre-Clinical Toxicity Testing
  • Track 1-3: Alternatives to Animal Testing
  • Track 1-4: Immunotoxicology
  • Track 1-5: Omics Technologies
  • Track 1-6: Genotoxic Chemotherapy
  • Track 1-7: Cancer Genetic Testing
  • Track 1-8: Cytotoxicity
  • Track 1-9: Gentotoxicity and Mutagenicity
  • Track 1-10: In Vivo Imaging
  • Track 1-11: Biologic Markers in Reproductive Toxicology
  • Track 1-12: The 3Rs
  • Track 1-13: Organ Specific Toxicity
  • Track 1-14: Systemic Toxicity

  • Track 2-1: Clinical Pharmacology
  • Track 2-2: Neuro Pharmacology
  • Track 2-3: Psycho Pharmacology
  • Track 2-4: Pharmacoepidemiology
  • Track 2-5: Systems Pharmacology
  • Track 2-6: Behavioural Pharmacology
  • Track 2-7: Pharmacogenetics
  • Track 2-8: ADME

  • Track 3-1: Human Experimental Toxicology
  • Track 3-2: Human Clinical Toxicology
  • Track 3-3: Health Research Policies
  • Track 3-4: Toxicology and Industrial Health
  • Track 3-5: Toxicology and Environmental Health
  • Track 3-6: Organ and Skin Toxicity
  • Track 3-7: Reproductive and Developmental Toxicology

  • Track 4-1: Chemical Warfare Agents
  • Track 4-2: Sources of Environmental Toxicity
  • Track 4-3: Ecotoxicology
  • Track 4-4: Metallic Toxicology
  • Track 4-5: Food Safety and Risk Assessment
  • Track 4-6: Human Health and Environmental Risk Assessment
  • Track 4-7: Environmental Management and Toxicology
  • Track 4-8: Environmental Contamination and Toxicology
  • Track 4-9: Pesticide Chemistry and Toxicology

  • Track 5-1: Drug and Chemical Toxicology
  • Track 5-2: Drug Toxicology Screening
  • Track 5-3: Advances in Drug Toxicology Testing
  • Track 5-4: Endocrine and Hormonal Toxicology

  • Track 6-1: Nanotoxicology
  • Track 6-2: Nanomedicine
  • Track 6-3: Toxic Mechanisms and Responses
  • Track 6-4: Xenobiotic Metabolism
  • Track 6-5: Therapies and Antidotes
  • Track 6-6: Teratogenesis
  • Track 6-7: CRISPR Technology
  • Track 6-8: Human Gene Editing
  • Track 6-9: Biomarkers
  • Track 6-10: Biodegradation
  • Track 6-11: Chemical Warfare Toxicology
  • Track 6-12: Particle and Fiber Toxicology

  • Track 7-1: Pharmacological and Toxicological Methods
  • Track 7-2: Regulatory Toxicology and Pharmacology
  • Track 7-3: Toxicology and Applied Pharmacology
  • Track 7-4: Elementary Pharmacology & Toxicology

  • Track 8-1: Toxicology Regulatory Services
  • Track 8-2: Toxicology Testing Services
  • Track 8-3: Toxicology Consultants

  • Track 10-1: Biochemical Toxicology
  • Track 10-2: Molecular Toxicology
  • Track 10-3: Biotransformation of Chemicals
  • Track 10-4: Food and Chemical Toxicology
  • Track 10-5: Food Safety and Toxicology
  • Track 10-6: Food and Cosmetic Toxicology
  • Track 10-7: Food Chemistry and Toxicology

  • Track 14-1: Cardiovascular Toxicology
  • Track 14-2: Placental Toxicology
  • Track 14-3: Pulmonary Toxicology
  • Track 14-4: Toxicology of Metals
  • Track 14-5: Toxicology of Marine Mammals
  • Track 14-6: Renal Toxicology
  • Track 14-7: Veterinary Toxicology
  • Track 14-8: Plant Toxicology
  • Track 14-9: Comprehensive Toxicology
  • Track 14-10: Predictive Toxicology
  • Track 14-11: Industrial Toxicology
  • Track 14-12: Interdisciplinary Toxicology
  • Track 14-13: Computational Toxicology
  • Track 14-14: Occupational Toxicology
  • Track 14-15: Regulatory Toxicology
  • Track 14-16: Genetic Toxicology
  • Track 14-17: Medicine and Medical Toxicology
  • Track 14-18: Clinical Toxicology
  • Track 14-19: Analytical Pharmacology